Effect of erythropoietin on anaemia in patients with myeloma receiving haemodialysis.
نویسندگان
چکیده
Discussion This study had investigated the dual role of parasympathetic efferent activity and plasma adrenaline in the pathogenesis ofnocturnal asthma. Parasympathetic blockade in this study caused a significant reversal ofthe nocturnal fall in peak flow rate as shown in our previous work.3 In the first arm of the study parasympathetic blockade reversed completely the nocturnal fall in peak flow rate, but the effect was not complete in the second arm. Infusions ofadrenaline in a dose more than sufficient to reverse the nocturnal fall in plasma adrenaline both before and after parasympathetic blockade produced no significant increase in the peak flow rate at 4 am. Thus, although infusions of adrenaline in higher concentrations can cause bronchodilatation in both normal and asthmatic subjects (fig 2),'4'5 alterations of plasma adrenaline within the concentrations seen on a diurnal basis do not have any significant physiological effect on expiratory airflow limitation either by direct action on bronchial smooth muscle, modulation of vagal neurotransmission,8 mediator release from inflammatory cells,4 16 or by increasing microvascular leakage.9 Our results agree with the earlier observation that a diurnal variation in pulmonary function can occur after adrenalectomy,'7 again confirming a lack of a primary role for adrenaline in nocturnal asthma. These observations do not detract from the therapeutic benefit of oral or inhaled 2 agonists in nocturnal asthma, when (as in this situation) pharmacological concentrations of the agonist are achieved at the receptor. We conclude that the nocturnal fall in plasma adrenaline does not account for the other factor(s) that act with parasympathetic nervous activity to increase airflow limitation at night in asthma. The effect of the a sympathetic and non-adrenergic non-cholinergic nerves and also the study of diurnal variation of airway oedema and inflammatory mediators in nocturnal asthma may be of relevance for future research.
منابع مشابه
PHARMA COKINETICS OF RECOMBINANT ERYTHROPOIETIN AND RED CELL METABOLISM IN HAEMODIALYSIS PATIENTS
The pharmacokinetics of recombinant human erythropoietin (rHuEpo) administered intravenously has been investigated in a group of five patients with chronic renal failure who were dialysis-dependent. The half-life of circulating erythropoietin decreased from 7.9±OA hr (mean ±SO) at the beginning of treatment to 6.2±O.6 hr after 6 weeks and 5A±O.9 hr after 4 months of treatment. In spite of t...
متن کاملDoes erythropoietin accelerate malignant transformation in multiple myeloma?
Growth factors or humoral agents can support haemopoiesis in various bone marrow disorders. They have the ability to act on multiple cell lineages and in myeloid cells, and the potential to act on the neoplastic equivalent of normal cells. Anaemia is a common feature of multiple myeloma seen in at least two-thirds of patients at presentation. Erythropoietin is increasingly being used with varia...
متن کاملEffectiveness of weekly darbepoetin alfa in the treatment of anaemia of HIV-infected haemodialysis patients.
BACKGROUND Anaemia is aggravated by the coexistence of chronic kidney disease (CKD) in patients infected with human immunodeficiency virus (HIV). Darbepoetin alfa effectively alleviates CKD-associated anaemia with less frequent dosing than recombinant human erythropoietin (EPO). The current study aimed to determine the efficacy, safety and cost-effectiveness of darbepoetin alfa compared with er...
متن کاملEffect of L-carnitine administration on erythropoietin use in thalassemic minor haemodialysis patients.
Effect of L-carnitine administration on erythropoietin use in thalassemic minor haemodialysis patients Sir, We read with great interest the recent letter by Arduini et al. [1], on the effect of L-carnitine (LC) on erythrocyte survival in haemodialysis patients. In the same issue, there is a paper by Hothi et al. [2] showing that plasma free-carnitine (FC) levels fell from 26. They conclude that...
متن کاملRenal association clinical practice guideline on Anaemia of Chronic Kidney Disease
Anaemia is a commonly diagnosed complication among patients suffering with chronic kidney disease. If left untreated, it may affect patient quality of life. There are several causes for anaemia in this patient population. As the kidney function deteriorates, together with medications and dietary restrictions, patients may develop iron deficiency, resulting in reduction of iron supply to the bon...
متن کاملAnaemia management protocols in the care of haemodialysis patients: examining patient outcomes.
AIMS AND OBJECTIVES To determine whether the use of a nurse-driven protocol in the haemodialysis setting is as safe and effective as traditional physician-driven approaches to anaemia management. BACKGROUND The role of haemodialysis nurses in renal anaemia management has evolved through the implementation of nurse-driven protocols, addressing the trend of exceeding haemoglobin targets and ris...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- BMJ
دوره 301 6750 شماره
صفحات -
تاریخ انتشار 1990